[Ossio in MassDevice] Ossio closes $38.5M Series C
Orthopedic fixation technology developer Ossio announced today that it closed a $38.5 million Series C financing round. Read...
Read MoreTag: ossio
[Ossio in Business Wire] OSSIO Announces U.S. Launch and First Commercial Use of OSSIOfiber® Suture Anchors, Expanding Patient Access to Growing Portfolio of Bio-Integrative Orthopedic Fixation Technology
WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., a fast-growing orthopedic fixation technology company, announced today the U.S. launch and first commercial use of OSSIOfiber® Suture Anchors, expanding patient access to the company’s growing portfolio of bio-integrative implants for use in foot/ankle, shoulder, knee, hand/wrist and elbow surgery. Read more...
Read More[Ossio in MassDevice] FDA clears Ossio’s OssioFiber suture anchors for bone fixation
Ossio announced today that it received the third FDA clearance for its OssioFiber product family in recent months. Read...
Read More[Ossio in Today’s Medical Developments] Laboratory blood glucose reference analyzer; Compression screw portfolio gets clearance
OSSIO Inc.’s OSSIOfiber compression screw portfolio received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis, and bone grafts of the upper extremity, fibula, knee, ankle, and foot in the presence of appropriate brace and/or immobilization. Read...
Read More[Ossio in This Week Orthopedics] OSSIOFIBER BIO-INTEGRATIVE COMPRESSION SCREWS CLEARED
Ossio, Inc.’s OSSIOfiber Compression Screws have received 510(k) clearance from the FDA. The screws are indicated for “maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis, and bone grafts, of the upper extremity, fibula, knee, ankle and foot in the presence of appropriate brace and/or immobilization,” according to FDA clearance documents. Read...
Read More
